Arcutis Biotherapeutics, Inc.: Form 10-Q/A for the period ended Mar 31, 2024
Filed with the SEC on Jul 24, 2024 and accepted by EDGAR at Jul 24, 2024, 16:10 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001193125-24-183778. Last ingested by Listed: Oct 28, 2026, 09:04 ET. Listed shows no prices and gives no investment advice.